Universal Competitors

U1HS34 Stock

BRL 293.93 0.00 0.00%

Universal Health Ser competes with Charter Communications, Zoom Video, and Monster Beverage; as well as few others. The company operates under Healthcare sector and is part of Medical Care Facilities industry. Analyzing Universal Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Universal Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Universal Health Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Universal Health competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
291.61	293.93	296.25

Details

Intrinsic

Valuation

Low	Real	High
238.70	241.02	323.32

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Universal Health. Your research has to be compared to or analyzed against Universal Health's peers to derive any actionable benefits. When done correctly, Universal Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Universal Health Ser.

Universal Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Universal Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Universal and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Universal Health Ser does not affect the price movement of the other competitor.

	CHCM34	N2LY34	Z1OM34	M1NS34	H1RL34
CHCM34		0.19	0.81	0.79	0.49	CHCM34
N2LY34	0.19		0.4	0.24	0.74	N2LY34
Z1OM34	0.81	0.4		0.85	0.77	Z1OM34
M1NS34	0.79	0.24	0.85		0.63	M1NS34
H1RL34	0.49	0.74	0.77	0.63		H1RL34
	CHCM34	N2LY34	Z1OM34	M1NS34	H1RL34

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Universal Stock performing well and Universal Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Universal Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CHCM34	1.86	0.26	0.08	(0.90)	2.52	(1.94)	4.82	(3.84)	23.36
N2LY34	1.22	0.08	0.04	0.20	1.49	(1.24)	2.34	(3.01)	8.80
Z1OM34	1.96	0.36	0.14	(0.97)	2.19	(2.12)	5.39	(4.05)	11.42
M1NS34	1.27	0.14	0.07	(0.65)	1.47	(1.62)	2.83	(2.76)	8.33
H1RL34	0.57	0.15	0.06	(0.73)	0.68	(1.98)	2.47	(0.90)	9.65

Unable to evaluate fundamental data of [CHCM34.SA, N2LY34.SA, Z1OM34.SA, M1NS34.SA, H1RL34.SA] at this time. Please try again later

All Fundamental Data

Universal Health Competitive Analysis

The better you understand Universal Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Universal Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Universal Health's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	U1HS34	CHCM34	N2LY34	Z1OM34	M1NS34	H1RL34
	0.00 293.93 Universal	0.79 35.08 Charter	0.43 112.81 Annaly	3.13 19.52 Zoom	0.13 39.47 Monster	0.79 185.14 Hormel
Market Volatility (90 Days Market Risk)	Very steady	Not too volatile	Very steady	Not too volatile	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	Modest	Modest	Good	OK	OK
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Unknown	Low	Low	Unknown
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Fairly Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Hold	Strong Sell	Hold	Strong Sell	Strong Sell	Strong Sell
Current Ratio	1.20 X	0.47 X		3.49 X	4.45 X
Net Asset	N/A	144.52 B		7.55 B	7.8 B
Profit Margin	8.88 %	0.09 %		0.16 %	0.19 %
EBITDA	2.02 B	20.92 B		1.11 B	1.85 B
Operating Margin	12.28 %	0.23 %		0.16 %	0.26 %
Current Valuation	20.64 B	839.88 B		86.53 B	259.19 B
Price To Book	2.63 X	6.50 X		3.65 X	7.73 X
Beta	1.2	1.13		-0.23	0.88
Number Of Employees	89 K	101.7 K		8.42 K	3.46 K
Shares Outstanding	340.51 M	9.16 B		7.31 B	4.18 B
Cash Flow From Operations	1.03 B	14.93 B		1.61 B	1.16 B
Total Debt	3.91 B	96.09 B		102.91 M	20.77 M
Return On Equity	17.6	0.38		0.13	0.19
Z Score	10.2	1.8		N/A	N/A
Return On Asset	7.51	0.0544		0.0586	0.13
Book Value Per Share	76.83 X	1.02 X		19.69 X	1.63 X
Total Asset	N/A	144.52 B		7.55 B	7.8 B
Debt To Equity	0.59 %	3.71 %		0.02 %	0 %
Last Dividend Paid	0.51	N/A		N/A	N/A
Shares Owned By Institutions	N/A	0.01 %		N/A	0.01 %
Market Capitalization	68.92 B	322.46 B		116.53 B	283.94 B
Price To Earning	3.15 X	38.78 X		3.89 X	4.51 X
Price To Earnings To Growth	N/A	0.29 X		N/A	3.42 X
Price To Sales	5.64 X	4.87 X		25.43 X	44.41 X
Net Income	1.08 B	5.05 B		1.38 B	1.38 B
Earnings Per Share	64.16 X	2.63 X		0.44 X	1.49 X
Revenue	12.21 B	54.02 B		4.1 B	5.54 B
Cash And Equivalents	199.02 M	1.71 B		4.69 B	2.55 B
Cash Per Share	2.39 X	0.16 X		15.92 X	0.60 X
Gross Profit	4.66 B	24.48 B		3.05 B	3.11 B
Day Typical Price	293.93	35.08	112.88	19.75	39.55	185.14
Accumulation Distribution	N/A	N/A	0.0018	0.0337	0.0168	N/A
Market Facilitation Index	N/A	N/A	0.2	0.68	0.67	N/A
Daily Balance Of Power	0.0	(9,223,372,036,855)	(2.45)	(0.93)	(0.07)	(9,223,372,036,855)
Period Momentum Indicator	N/A	(0.28)	(0.49)	(0.63)	(0.05)	(1.48)
Rate Of Daily Change	1.0	0.99	1.0	0.97	1.0	0.99
Day Median Price	293.93	35.08	112.91	19.86	39.59	185.14
Price Action Indicator	N/A	(0.14)	(0.34)	(0.65)	(0.14)	(0.74)
Coefficient Of Variation	(54,890)	1126.55	1792.55	700.12	1108.29	780.73
Mean Deviation	0.466	1.86	1.22	1.96	1.27	0.5705
Jensen Alpha	(0.02)	0.2604	0.0766	0.3636	0.142	0.1482
Total Risk Alpha	(0.07)	0.1897	0.0471	0.3006	0.1022	0.1182
Sortino Ratio	N/A	0.0837	0.041	0.1356	0.0714	0.0564
Downside Variance	N/A	8.08	2.64	6.27	2.86	5.09
Standard Deviation	2.32	2.99	1.69	2.57	1.64	1.21
Kurtosis	29.1	8.2	1.97	0.2523	1.33	10.23
Potential Upside	0.4511	4.82	2.34	5.39	2.83	2.47
Treynor Ratio	(0.03)	(0.90)	0.1954	(0.97)	(0.65)	(0.73)
Maximum Drawdown	24.51	23.36	8.8	11.42	8.33	9.65
Variance	5.38	8.94	2.85	6.61	2.7	1.46
Market Risk Adjusted Performance	(0.02)	(0.89)	0.2054	(0.96)	(0.64)	(0.72)
Risk Adjusted Performance	0.0051	0.0781	0.0497	0.1207	0.077	0.1055
Skewness	(1.65)	1.11	0.5197	0.1177	(0.61)	0.0026
Semi Deviation	N/A	2.52	1.49	2.19	1.47	0.682
Information Ratio	(0.01)	0.0796	0.0395	0.1321	0.0735	0.1053
Value At Risk	N/A	(3.84)	(3.01)	(4.05)	(2.76)	(0.90)
Expected Short fall	N/A	(1.94)	(1.24)	(2.12)	(1.62)	(1.98)
Downside Deviation	N/A	2.84	1.63	2.5	1.69	2.26
Semi Variance	N/A	6.36	2.22	4.78	2.17	0.4651

Universal Health Competition Performance Charts

Five steps to successful analysis of Universal Health Competition

Universal Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Universal Health Ser in relation to its competition. Universal Health's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Universal Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Universal Health's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Universal Health Ser, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Universal Health position

In addition to having Universal Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Most Shorted Equities Thematic Idea Now

Most Shorted Equities

Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 142 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Universal Stock

Universal Health financial ratios help investors to determine whether Universal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Universal with respect to the benefits of owning Universal Health security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC